In this article, we will list the 5 Best Medical Stocks to Invest In According to Billionaires. Please visit 12 Best Medical Stocks to Invest In According to Billionaires if you would like to see the extended list and the methodology behind it.
5. Danaher Corporation (NYSE:DHR)
Number of Billionaire Holders: 31
Danaher Corporation (NYSE:DHR) is one of the best medical stocks to invest in according to billionaires. RBC Capital resumed coverage of Danaher Corporation (NYSE:DHR) with an Outperform rating on May 14, setting a price target of $200. The firm told investors in a research note that it sees the company’s growth recovering with an improvement in the bioprocess market. It further added that factors like the lapping of “idiosyncratic headwinds”, a sustained bioprocess rebound, and end market improvement put the company’s 6% revenue growth target within reach for 2027.
For reference, in its financial results for fiscal Q1 2026, Danaher Corporation (NYSE:DHR) reported net earnings of $1.0 billion, or $1.45 per diluted common share. Revenues for the quarter rose 3.5% year-over-year to $6.0 billion, while non-GAAP core revenue grew 0.5% year-over-year. The company also reported that operating cash flow was $1.3 billion, while non-GAAP free cash flow was $1.1 billion.
Danaher Corporation (NYSE:DHR) designs, manufactures, and markets professional, medical, industrial, and commercial products and services, making it a significant diagnostics stock. It operates through Diagnostics, Biotechnology, Life Sciences, and Environmental and Applied Solutions.
4. Intuitive Surgical, Inc. (NASDAQ:ISRG)
Number of Billionaire Holders: 31
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the best medical stocks to invest in according to billionaires. Intuitive Surgical, Inc. (NASDAQ:ISRG) announced on May 21 several recent and upcoming innovations, which included enhancements across da Vinci 5 and its supporting ecosystem, advancements designed to enhance product and instrument security and reliability, and extended‑use Force Feedback instruments.
Management stated that over 100 updates and user experience improvements will be available to users soon, including telepresence enhancements, Da Vinci 5 surgeon console mobile login, and SimNow 2 targeted learning. Additional features are also expected to be available in the United States later this year, including digital ruler, Surgeon-initiated tool eject, and Multi-arm targeting. These are subject to regulatory clearance.
For reference, in its financial results for fiscal Q1, Intuitive Surgical, Inc. (NASDAQ:ISRG) reported that worldwide procedures for da Vinci and Ion combined grew around 17% compared to fiscal Q1 2025, with Da Vinci procedures growing approximately 16%, and Ion procedures growing approximately 39%. Revenue for the quarter came up to $2.77 billion, up 23% compared to $2.25 billion in the prior year period. The company also reported that it placed 431 da Vinci surgical systems, compared with 367 in fiscal Q1 2025.
Intuitive Surgical, Inc. (NASDAQ:ISRG) has an elaborate ecosystem of services and products that provide robotic-assisted surgical solutions and invasive care. Its products include the Ion Endoluminal and the Da Vinci Surgical systems.
3. Eli Lilly and Company (NYSE:LLY)
Number of Billionaire Holders: 31
Eli Lilly and Company (NYSE:LLY) is one of the best medical stocks to invest in according to billionaires. Eli Lilly and Company (NYSE:LLY) received a rating update from Truist on May 1, with the firm maintaining a Buy rating on the shares with a price target of $1,281. It stated that the company’s retatrutide Phase 3 clinical trial data in obesity announced the same day marks a new benchmark for anti-obesity medications, showing that patients on retatrutide high dose of 12 mg saw 28.3% weight loss at 80 weeks and 30.3% at 104 weeks. The firm told investors in a research note that it believes this will support retatrutide approval and use in patients that are not adequately served with existing incretin options.
The same day, Wolfe Research also maintained an Outperform rating on Eli Lilly and Company (NYSE:LLY) with a price target of $1,350. It told investors in a research note that the company’s reported pivotal phase 3 results for retatrutide further bolster its GLP-1 franchise leadership and differentiation in obesity therapeutics.
Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology, neuroscience, and other therapies.
2. Boston Scientific Corporation (NYSE:BSX)
Number of Billionaire Holders: 36
Boston Scientific Corporation (NYSE:BSX) is one of the best medical stocks to invest in according to billionaires. BofA cut the price target on Boston Scientific Corporation (NYSE:BSX) to $68 from $105 on May 18, reaffirming a Buy rating on the shares. The firm told investors that after having hosted 34 medtech companies last week in Las Vegas, it updated several price targets for “the new reality of medtech valuations” in a year of few product cycles, inflation kicking up post-war, ACA, and utilization worries, and “data centers over healthcare”.
In another development, Argus cut the price target on Boston Scientific Corporation (NYSE:BSX) to $95 from $115 on April 27, reaffirming a Buy rating on the shares. The rating update came after the company’s fiscal Q1 earnings and guidance cut, with the firm telling investors in a research note that the stock has recently underperformed the broader market. However, it added that the company remains well-positioned in high-growth areas such as cardiovascular, electrophysiology, and neuromodulation, with the management setting more achievable objectives by cutting its outlook. Argus believes that Boston Scientific Corporation’s (NYSE:BSX) price weakness creates a buying opportunity.
Boston Scientific Corporation (NYSE:BSX) manufactures, develops, and markets medical devices used in interventional medical procedures. Its operations are divided into Cardiovascular and MedSurg segments. The Cardiovascular segment covers Cardiology and Peripheral Interventions, while the MedSurg segment comprises Urology, Endoscopy, and Neuromodulation.
1. UnitedHealth Group Incorporated (NYSE:UNH)
Number of Billionaire Holders: 37
UnitedHealth Group Incorporated (NYSE:UNH) is one of the best medical stocks to invest in according to billionaires. UnitedHealth Group Incorporated (NYSE:UNH) reported on May 11 that Optum Rx announced a new pharmacy care model that changes the pricing and delivery of pharmacy benefits by replacing the traditional approach of prices set by manufacturers or prescription volume with a transparent, fee‑based structure that is offered to every Optum Rx PBM customer. Management stated that the model is specialized to fully align incentives with patients and plan sponsors. The new approach would allow Optum Rx clients a pricing structure with monthly, clearly defined fees per member, independent of manufacturers’ list prices or prescription volume, which would help eliminate spread pricing and similar practices.
In a separate development, UnitedHealth Group Incorporated (NYSE:UNH) received a rating update from Goldman Sachs on May 1, with the firm adding the stock to its US Conviction list. Goldman Sachs has a Buy rating on the shares with a price target of $435 and believes that the company is nearing the bottom of its underwriting cycle for Medicare Advantage, which presents 40% of its business. The rating update came as part of the firm’s monthly update.
UnitedHealth Group Incorporated (NYSE:UNH) provides healthcare coverage, data consultancy, and software services. It operates through the OptumRx, OptumInsight, OptumHealth, and UnitedHealthCare segments.
While we acknowledge the potential of UNH to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than UNH and that has 100x upside potential, check out our report about the cheapest AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
